Predominance of the Rare EGFR Mutation p.L861Q in Tunisian Patients with Non-Small Cell Lung Carcinoma

Objectives: Several new cancer therapies targeting signaling pathways involved in the growth and progression of cancer cells were developed as personalized medicine. Our study aimed to identify epidermal growth factor receptor (EGFR) mutations for TKI treatment in non-small-cell lung cancer (NSCLC)...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdelmaksoud-Dammak, Rania, Ammous-Boukhris, Nihel, Saadallah-Kallel, Amèna, Charfi, Slim, Khemiri, Souhir, Khemakhem, Rim, Kallel, Nesrin, Ben Kridis-Rejeb, Wala, Sallemi-Boudawara, Tahya, Khanfir, Afef, Yangui, Ilhem, Daoud, Jamel, Mokdad-Gargouri, Raja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9407939/
https://www.ncbi.nlm.nih.gov/pubmed/36011410
http://dx.doi.org/10.3390/genes13081499

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9407939/
https://www.ncbi.nlm.nih.gov/pubmed/36011410
http://dx.doi.org/10.3390/genes13081499

Ejemplares similares